Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,394 | 9,919 | 1,274 | 2,285 | 167 |
| Receivables | 933 | 25 | 23 | 24 | 25 |
| TOTAL | $9,449 | $10,029 | $1,430 | $2,489 | $219 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 1 | 1 | 1 |
| Other Non-Current Assets | 59 | 57 | 126 | 57 | 1,186 |
| TOTAL | $59 | $58 | $126 | $58 | $1,188 |
| Total Assets | $9,508 | $10,086 | $1,556 | $2,547 | $1,407 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 418 | 158 | 338 | 286 | 602 |
| Accrued Expenses | 1,096 | 251 | 305 | 127 | 913 |
| Other current liabilities | N/A | N/A | N/A | N/A | 303 |
| TOTAL | $3,421 | $1,409 | $643 | $413 | $5,024 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,908 | 1,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | -10 | 0 | 0 | 5 | -65 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,421 | $1,409 | $643 | $413 | $5,024 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 1 | 1 | 1 | N/A |
| Common Shares | 77 | 77 | 65 | 64 | 2 |
| Retained earnings | -65,255 | -62,565 | -61,210 | -59,668 | -56,862 |
| Other shareholders' equity | 56 | 45 | 46 | 16 | 43,187 |
| TOTAL | $6,087 | $8,677 | $914 | $2,134 | $-3,618 |
| Total Liabilities And Equity | $9,508 | $10,086 | $1,556 | $2,547 | $1,407 |